These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20646576)

  • 1. [Prognostic factors and reproductive outcomes of borderline ovarian tumors: a review of 186 patients].
    Tao T; Cao DY; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Guo LN; Shen K
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(19):1304-8. PubMed ID: 20646576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors predicting recurrence in borderline ovarian tumors.
    Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
    Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility and recurrence results of conservative surgery for borderline ovarian tumors.
    Boran N; Cil AP; Tulunay G; Ozturkoglu E; Koc S; Bulbul D; Kose MF
    Gynecol Oncol; 2005 Jun; 97(3):845-51. PubMed ID: 15896834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Ren J; Peng Z; Yang K
    Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
    Anfinan N; Sait K; Ghatage P; Nation J; Chu P
    Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomyxoma peritonei: a review of 23 cases.
    Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
    Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
    De Iaco P; Ferrero A; Rosati F; Melpignano M; Biglia N; Rolla M; De Aloysio D; Sismondi P
    Eur J Surg Oncol; 2009 Jun; 35(6):643-8. PubMed ID: 19013745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
    Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
    Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors.
    Song T; Choi CH; Kim HJ; Lee W; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):204-8. PubMed ID: 21306816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.